Showing results (201-210 of 270) with videos related to
Sort By:
Pageof 27
European Journal of Immunology|June 1, 1991
Interleukin 2 counteracts the inhibition of cytotoxic T lymphocytes by cholera toxin in vitro and in vivoM Moscovitch-Lopatin, R J Petrillo, O G Pankewycz, et al.Transplantation|November 1, 1987
Differential effect of gamma-irradiated and heat-treated lymphocytes on T cell activation, and interleukin-2 and interleukin-3 release in the human mixed lymphocyte reactionR Loertscher, M Abbud-Filho, A B Leichtman, et al.Biochemical Society Symposium|January 1, 1987
Genetic assembly and selective toxicity of diphtheria-toxin-related polypeptide hormone fusion proteinsJ R Murphy, W Bishai, D Williams, et al.Archives of Internal Medicine|November 1, 1978
Vestibular toxicity of gentamicin. Incidence in patients receiving long-term hemodialysis therapyP Gailiunas, M Dominguez-Moreno, M Lazarus, et al.Transplantation|December 1, 2001
Intragraft activation of genes encoding cytotoxic T lymphocyte effector molecules precedes the histological evidence of rejection in human cardiac transplantationN Shulzhenko, A Morgun, X X Zheng, et al.Blood|April 1, 1996
Irradiated B7-1 transduced primary acute myelogenous leukemia (AML) cells can be used as therapeutic vaccines in murine AMLK Dunussi-Joannopoulos, H J Weinstein, P W Nickerson, et al.Journal of Immunology (Baltimore, Md. : 1950)|May 1, 1984
Dual parameter flow cytometric analysis of DNA content, activation antigen expression, and T cell subset proliferation in the human mixed lymphocyte reactionJ M Williams, R Loertscher, T Cotner, et al.Digestive Diseases and Sciences|June 1, 1992
Tumor necrosis factor-alpha, interleukin-1 beta, and interleukin-6 expression in inflammatory bowel diseaseC Stevens, G Walz, C Singaram, et al.Cancer Research|July 15, 1989
Cytotoxicity of interleukin 2-toxin toward lymphocytes from patients with adult T-cell leukemiaT Kiyokawa, K Shirono, T Hattori, et al.Transplantation|November 1, 1975
Modification of the rat alloimmune response by enhancing antibodies and the role of blocking factors in the survival of renal graftsT B Strom, C B Carpenter, M R Garovoy, et al.Pageof 27